Sanders Capital CME trades
Lewis Sanders
Lewis Sanders CME Group Inc stake
total: 133
Trades details
- Total transactions:
- 5
- New positions:
- 1
- Added:
- 2
- Reduced:
- 2
- Held since:
- 2025 Q3
- Held for:
- 5 quarters
- Latest activity:
- 2026 Q3
According to 2026 Q3 report, Lewis Sanders holds 5,058,865 CME Group Inc (CME) shares with a market value of roughly $1.33B accounting for 1.28% of the overall portfolio. To date, the estimated cost basis is nearly $261.65 for "buy" trades and estimated average "sell" price is $283.6. Sanders Capital first purchased CME in 2025 Q3, initially acquiring about 3.73M shares. Since the initial investment in CME Group Inc (CME), Sanders Capital has made 4 more transactions.
When did Lewis Sanders buy CME Group Inc (CME)?
Lewis Sanders first invested in CME Group Inc (CME) in 2025 Q3 at the reported quarter-end price of $270.19 per share.
What's the cost basis of Sanders Capital's CME stake?
The estimated cost basis for CME Group Inc (CME) stake is around $261.65 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $261.64
- Weighted AVG sell price:
- $283.60
Lewis Sanders's historical trades in CME Group Inc
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q3
|
1.28%
|
5,058,865
|
$261.98
|
$1,325,321,453
|
-0.18% (-8,875)
|
-0%
|
|
2026 Q2
|
1.12%
|
5,067,740
|
$220.83
|
$1,119,109,024
|
+21.79% (+906,550)
|
+0.2%
|
|
2026 Q1
|
1.46%
|
4,161,190
|
$295.35
|
$1,229,007,467
|
-0.39% (-16,325)
|
-0.01%
|
|
2025 Q4
|
1.31%
|
4,177,515
|
$273.08
|
$1,140,795,796
|
+12.10% (+450,760)
|
+0.14%
|
|
2025 Q3
|
1.24%
|
3,726,755
|
$270.19
|
$1,006,931,933
|
new
|
+1.24%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.